Wearable Sensors, Data Processing, and Artificial Intelligence in Pregnancy Monitoring: A Review

Innovations in maternal-fetal dermatology: A focus on artificial intelligence-driven diagnostics, global disparities, and transformative care

Pregnancy-associated dermatologic conditions emerge from intricate hormonal, immunological, genetic, and environmental changes, often complicating maternal and neonatal outcomes. Such changes can also impact the course of pre-existing skin disease during gestation. There are persistent gaps in clinical research, including the underrepresentation of pregnant patients, limited therapeutic options, and health disparities, continue to challenge optimal care. Recent advances in artificial intelligence offer promising opportunities for early diagnosis, enhanced risk assessment and drug safety, and expanded care access, particularly in underserved populations. Cultural, demographic, and genetic factors critically shape dermatologic presentations and outcomes, while inequities in data representation, algorithmic bias, and healthcare accessibility remain significant barriers. By integrating interdisciplinary innovations with culturally sensitive strategies, we propose a framework to optimize and globalize maternal-fetal dermatologic care.

Advancements in Wearable and Implantable BioMEMS Devices: Transforming Healthcare Through Technology

Wearable and implantable BioMEMSs (biomedical microelectromechanical systems) have transformed modern healthcare by enabling continuous, personalized, and minimally invasive monitoring, diagnostics, and therapy. Wearable BioMEMSs have advanced rapidly, encompassing a diverse range of biosensors, bioelectronic systems, drug delivery platforms, and motion tracking technologies. These devices enable non-invasive, real-time monitoring of biochemical, electrophysiological, and biomechanical signals, offering personalized and proactive healthcare solutions. In parallel, implantable BioMEMS have significantly enhanced long-term diagnostics, targeted drug delivery, and neurostimulation. From continuous glucose and intraocular pressure monitoring to programmable drug delivery and bioelectric implants for neuromodulation, these devices are improving precision treatment by continuous monitoring and localized therapy. This review explores the materials and technologies driving advancements in wearable and implantable BioMEMSs, focusing on their impact on chronic disease management, cardiology, respiratory care, and glaucoma treatment. We also highlight their integration with artificial intelligence (AI) and the Internet of Things (IoT), paving the way for smarter, data-driven healthcare solutions. Despite their potential, BioMEMSs face challenges such as regulatory complexities, global standardization, and societal determinants. Looking ahead, we explore emerging directions like multifunctional systems, biodegradable power sources, and next-generation point-of-care diagnostics. Collectively, these advancements position BioMEMS as pivotal enablers of future patient-centric healthcare systems.